Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - amiloride hydrochloride - oral tablet - 5mg

Ísrael - enska - Ministry of Health

teva israel ltd - amiloride as hydrochloride anhydrous; hydrochlorothiazide - tablets - amiloride as hydrochloride anhydrous 5 mg; hydrochlorothiazide 50 mg - hydrochlorothiazide and potassium-sparing agents - hypertension: kaluril is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of the disease. edema: edema associated with congestive heart failure and hepatic cirrhosis.

Malta - enska - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - amiloride hydrochloride - oral solution - amiloride hydrochloride 5.675 mg - diuretics

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - amiloride hydrochloride dihydrate 5mg - tablet - 5 mg - active: amiloride hydrochloride dihydrate 5mg

Írland - enska - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - losartan potassium, hydrochlorothiazide - film coated tablet - 50/12.5 milligram - angiotensin ii antagonists and diuretics

Írland - enska - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - losartan potassium, hydrochlorothiazide - film coated tablet - 100/25 milligram - angiotensin ii antagonists and diuretics

Malta - enska - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - fosinopril sodium, hydrochlorothiazide - tablet - fosinopril sodium 20 mg hydrochlorothiazide 12.5 mg - agents acting on the renin-angiotensin system

Malta - enska - Medicines Authority

generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - hydrochlorothiazide, lisinopril - tablet - hydrochlorothiazide 12.5 mg lisinopril 20 mg - agents acting on the renin-angiotensin system

Kanada - enska - Health Canada

aa pharma inc - hydrochlorothiazide; amiloride hydrochloride - tablet - 50mg; 5mg - hydrochlorothiazide 50mg; amiloride hydrochloride 5mg - potassium-sparing diuretics

Bandaríkin - enska - NLM (National Library of Medicine)

northwind pharmaceuticals, llc - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd) - hydrochlorothiazide 25 mg - lisinopril and hydrochlorothiazide tablets usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a